Pharmafile Logo
Pharmafocus logo
Advanced Search

generics

Showing 15 posts of 209 posts found.

Cephalon completes acquisition of generics firm Mepha

April 16, 2010
Sales and Marketing Cephalon, generics

Specialist pharmaceutical company Cephalon has completed the $615.4 million acquisition of Mepha. Based in Switzerland, Mepha specialises in using reformulation …

News

GSK agrees generic deal on Malarone

April 13, 2010
Sales and Marketing GSK, depression, generics

Generic versions of two GlaxoSmithKline products have received the green light for launch in the US. Mylan has been given …

News
Cozaar

Merck to be hit by Cozaar generics

April 9, 2010
Merck, Teva, generics

Generic versions of Merck’s hypertension treatments Cozaar and Hyzaar are to be launched in the US for the first time. …

News

Generic substitution will not deliver significant NHS savings, says EMIG

March 31, 2010
Sales and Marketing EMIG, NHS, generics

The Department of Health’s plans for automatic generic substitution will not result in significant savings for the NHS and should …

News

GSK breathes more easily after Sandoz exit

March 24, 2010
Sales and Marketing Advair, Sandoz, generics, vectura

Sandoz has exited a deal to launch a generic rival to GSK’s top selling respiratory drug Advair. Sandoz, the generics …

News

AstraZeneca signs generics deal with Torrent

March 11, 2010
AZ, generics

AstraZeneca have signed a license and supply agreement with Indian-based Torrent Pharma that will boost its generics portfolio. Torrent will …

News
Ratiopharm HQ

Pfizer muscles in on Ratiopharm sale

March 11, 2010
Sales and Marketing Pfizer, Ratiopharm, Teva, generics

Pfizer has reportedly bid $4 billion for German generics firm Ratiopharm in a bid to rapidly expands its portfolio in …

News

Brennan rejects generics diversification model

February 11, 2010
Sales and Marketing AstraZeneca, biosimilars, em, generics, industry

AstraZeneca’s chief executive David Brennan has rejected the strategy of diversification into generics and biosimilars being pursued by many of …

News

Actavis looks internally and externally for growth

February 10, 2010
Manufacturing and Production Actavis, generics

Actavis is planning to increase the size of its manufacturing site in Iceland in order to boost output to around …

News

Generics firm press for ‘clear and open’ market

February 8, 2010
Sales and Marketing generics, industry

Generic drug companies have set out their vision of a more ‘clear’ and ‘open’ market in Europe. Greg Perry, director …

News

US generics company expands into Eastern Europe

January 19, 2010
Sales and Marketing Alvogen, Eastern Europe, generics

US generics company Alvogen has announced an ambitious expansion into the lucrative markets of Eastern Europe. The company has opened …

News

Commission probes Lundbeck on alleged generic blocking

January 18, 2010
Sales and Marketing European Commission, Lundbeck, generics, kroes

The European Commission has confirmed it is to investigate Lundbeck for alleged anti-competitive behaviour relating to its anti-depressant Cipramil. The …

News
GP writing prescription

England moves forward on generic substitution

January 8, 2010
Sales and Marketing NHS, generics, substitution

The UK Department of Health has started a consultation on proposals that would allow generic medicines to be substituted for …

News

Pharma mergers and acquisitions in 2009

December 22, 2009
Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …

Feature
EU flag

Commission launches new wave of anti-trust raids

December 15, 2009
Sales and Marketing Europe, European Commission, Lundbeck, Teva, generics, kroes

The European Commission has launched a new series of raids on pharmaceutical companies as part of its crackdown on alleged …

News

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024